Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Redburn Atlantic
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by research analysts at Redburn Atlantic from a “sell” rating to a “neutral” rating in a report issued on Monday, Marketbeat reports. The brokerage presently has a $188.00 target price on the medical research company’s stock. Redburn Atlantic’s target price would suggest a potential […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by research analysts at Redburn Atlantic from a “sell” rating to a “neutral” rating in a report issued on Monday, Marketbeat reports. The brokerage presently has a $188.00 target price on the medical research company’s stock. Redburn Atlantic’s target price would suggest a potential […]
